PMID- 27781339 OWN - NLM STAT- MEDLINE DCOM- 20180215 LR - 20181202 IS - 1365-2982 (Electronic) IS - 1350-1925 (Print) IS - 1350-1925 (Linking) VI - 29 IP - 4 DP - 2017 Apr TI - Tumor necrosis factor alpha derived from classically activated "M1" macrophages reduces interstitial cell of Cajal numbers. LID - 10.1111/nmo.12984 [doi] AB - BACKGROUND: Delayed gastric emptying in diabetic mice and humans is associated with changes in macrophage phenotype and loss of interstitial cells of Cajal (ICC) in the gastric muscle layers. In diabetic mice, classically activated M1 macrophages are associated with delayed gastric emptying, whereas alternatively activated M2 macrophages are associated with normal gastric emptying. This study aimed to determine if secreted factors from M1 macrophages could injure mouse ICC in primary culture. METHODS: Cultures of gastric ICC were treated with conditioned medium (CM) from activated bone marrow-derived macrophages (BMDMs) and the effect of CM was quantified by counting ICC per high-powered field. KEY RESULTS: Bone marrow-derived macrophages were activated to a M1 or M2 phenotype confirmed by qRT-PCR. Conditioned medium from M1 macrophages reduced ICC numbers by 41.1%, whereas M2-CM had no effect as compared to unconditioned, control media. Immunoblot analysis of 40 chemokines/cytokines found 12 that were significantly increased in M1-CM, including tumor necrosis factor alpha (TNF-alpha). ELISA detected 0.697+/-0.03 ng mL(-1) TNF-alpha in M1-CM. Recombinant mouse TNF-alpha reduced Kit expression and ICC numbers in a concentration-dependent manner (EC50 = 0.817 ng mL(-1) ). Blocking M1-CM TNF-alpha with a neutralizing antibody preserved ICC numbers. The caspase inhibitor Z-VAD.fmk partly preserved ICC numbers (cells/field; 6.63+/-1.04, 9.82+/-1.80 w/Z-VAD.fmk, n=6, P<.05). CONCLUSIONS & INFERENCES: This work demonstrates that TNF-alpha secreted from M1 macrophages can result in Kit loss and directly injure ICC in vitro partly through caspase-dependent apoptosis and may play an important role in ICC depletion in diabetic gastroparesis. CI - (c) 2016 John Wiley & Sons Ltd. FAU - Eisenman, S T AU - Eisenman ST AD - Enteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA. FAU - Gibbons, S J AU - Gibbons SJ AD - Enteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA. FAU - Verhulst, P-J AU - Verhulst PJ AD - Enteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA. FAU - Cipriani, G AU - Cipriani G AD - Enteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA. FAU - Saur, D AU - Saur D AD - Department of Internal Medicine II, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany. FAU - Farrugia, G AU - Farrugia G AD - Enteric NeuroScience Program, Mayo Clinic, Rochester, MN, USA. LA - eng GR - P01 DK068055/DK/NIDDK NIH HHS/United States GR - P30 DK084567/DK/NIDDK NIH HHS/United States GR - R01 DK057061/DK/NIDDK NIH HHS/United States PT - Journal Article DEP - 20161025 PL - England TA - Neurogastroenterol Motil JT - Neurogastroenterology and motility JID - 9432572 RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - Cell Count/methods MH - Cells, Cultured MH - Dose-Response Relationship, Drug MH - Gene Knock-In Techniques MH - Interstitial Cells of Cajal/drug effects/*metabolism MH - Macrophages/*metabolism MH - Mice MH - Mice, Inbred BALB C MH - Tumor Necrosis Factor-alpha/*metabolism/pharmacology PMC - PMC5367986 MID - NIHMS821183 OTO - NOTNLM OT - caspase-mediated apoptosis OT - cell death OT - cytokines OT - diabetic gastroparesis OT - gastrointestinal motility EDAT- 2016/10/27 06:00 MHDA- 2018/02/16 06:00 PMCR- 2018/04/01 CRDT- 2016/10/27 06:00 PHST- 2016/05/09 00:00 [received] PHST- 2016/09/20 00:00 [revised] PHST- 2016/09/28 00:00 [accepted] PHST- 2016/10/27 06:00 [pubmed] PHST- 2018/02/16 06:00 [medline] PHST- 2016/10/27 06:00 [entrez] PHST- 2018/04/01 00:00 [pmc-release] AID - 10.1111/nmo.12984 [doi] PST - ppublish SO - Neurogastroenterol Motil. 2017 Apr;29(4):10.1111/nmo.12984. doi: 10.1111/nmo.12984. Epub 2016 Oct 25.